Montreux_bio_action_michael_tablet_v2 Montreux_bio_action_michael_tablet_v2
return to team

Michael Matly, M.D.

Managing Director

Dr. Matly is a Managing Director at Montreux Equity Partners bringing significant experience in the health services and technology sectors.

Dr. Matly has been actively involved in Montreux's late-stage investments in health services and technology. He currently serves on the boards of Tiger Connect, Kareo, Pure Life Renal, and Pulmonx and actively supports Montreux’s investment in KNOW Foods. Previously, he represented Montreux on the board of MINDBODY Online (NASDAQ: MB). He was also involved with a number of exited Montreux portfolio companies including Epirus Biopharmaceuticals (NASDAQ: EPRS) and Pivot Medical (acquired by Stryker).

Before joining Montreux, Dr. Matly led Business Development and New Ventures at the Mayo Clinic Center for Innovation. Dr. Matly’s responsibilities included new venture incubation, new product development for Mayo Clinic’s consumer offerings, and strategic initiatives between Mayo Clinic and Fortune 100 companies from the retail, consumer, payer, technology, communications, and food/nutrition sectors.

Dr. Matly is a founding advisor to Rock Health, a leading digital health incubator based in San Francisco. He also serves as a Board Director for the Order of Malta Clinic in Oakland, CA.

Dr. Matly completed his M.D. from the Mayo Clinic, M.B.A. from Harvard Business School, and B.S. from Cornell University.